Erbitux: should sensitivity be tested before administering this anticancer treatment?

A medical debate is emerging on the need to systematize sensitivity testing before prescribing Erbitux, a targeted anticancer drug.

Published 6sem1 sourceNotableupdated 6sem

≈ 21sSpeed

The fact

This issue aims to optimize treatment effectiveness and avoid adverse effects in non-responsive patients.

Therapeutic recommendations could be revised to incorporate systematic pre-screening.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on June 9, 2026